Deep Learning to Predict Geographic Atrophy Area and Growth Rate from Multimodal Imaging
Neha Anegondi1, Simon S Gao1, Verena Steffen2
1Clinical Imaging Group, Genentech, Inc., South San Francisco, California; Roche Ophthalmology Personalized Healthcare, Genentech, Inc., South San Francisco, California.
Deep learning models accurately predict geographic atrophy (GA) growth rates using fundus autofluorescence (FAF) and OCT imaging. These predictions can enhance clinical trial power by adjusting for prognostic covariates.
Area of Science:
- Ophthalmology
- Medical Imaging
- Artificial Intelligence
Background:
- Geographic atrophy (GA) is a leading cause of vision loss.
- Accurate prediction of GA growth rate is crucial for clinical trial design and patient management.
- Current methods for assessing GA progression can be time-consuming and subjective.
Purpose of the Study:
- To develop and validate deep learning models for predicting the annualized geographic atrophy (GA) growth rate.
- To utilize fundus autofluorescence (FAF) images and spectral-domain optical coherence tomography (OCT) volumes for GA growth prediction.
- To assess the potential of these models for prognostic covariate adjustment in clinical trials.
Main Methods:
- Retrospective analysis of GA growth rate estimation using linear fit of lesion area over two years.
- Development of three multitask deep learning models: FAF-only, OCT-only, and multimodal (FAF + OCT).
- Training and testing models on development, holdout, and independent test datasets from multiple clinical trials.
Main Results:
- Multitask deep learning models demonstrated high accuracy in predicting GA lesion area (r² up to 0.98) and growth rate (r² up to 0.65) on independent test sets.
- The FAF-only model showed strong performance for both lesion area and growth rate prediction.
- Model performance was evaluated using squared Pearson correlation coefficient (r²) with confidence intervals.
Conclusions:
- Deep learning models can effectively predict individual GA area and growth rates from baseline FAF and OCT imaging.
- The developed models show feasibility for use in prognostic covariate adjustment to improve clinical trial power.
- This approach offers a promising tool for advancing research and treatment strategies for geographic atrophy.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
14:27Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
